KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) FCF Payout Ratio (2016 - 2026)

Bristol Myers Squibb has reported FCF Payout Ratio over the past 18 years, most recently at 1.69 for Q1 2026.

  • Quarterly FCF Payout Ratio rose 128.23% to 1.69 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.43 through Mar 2026, up 13.5% year-over-year, with the annual reading at 0.39 for FY2025, 12.6% up from the prior year.
  • FCF Payout Ratio was 1.69 for Q1 2026 at Bristol Myers Squibb, up from 0.79 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 1.69 in Q1 2026 and troughed at 0.01 in Q2 2022.
  • The 5-year median for FCF Payout Ratio is 0.35 (2025), against an average of 0.48.
  • Year-over-year, FCF Payout Ratio surged 12086.9% in 2023 and then plummeted 39.81% in 2025.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.39 in 2022, then fell by 23.54% to 0.3 in 2023, then grew by 1.41% to 0.3 in 2024, then skyrocketed by 162.33% to 0.79 in 2025, then surged by 115.41% to 1.69 in 2026.
  • Per Business Quant, the three most recent readings for BMY's FCF Payout Ratio are 1.69 (Q1 2026), 0.79 (Q4 2025), and 0.21 (Q3 2025).